Reversal of oncogene transformation and suppression of tumor growth by the novel IGF1R kinase inhibitor A-928605
<p>Abstract</p> <p>Background</p> <p>The insulin-like growth factor (IGF) axis is an important signaling pathway in the growth and survival of many cell and tissue types. This pathway has also been implicated in many aspects of cancer progression from tumorigenesis to m...
Main Authors: | Buchanan Fritz G, Donawho Cherrie, Sheppard George S, Johnson Eric F, Soni Niru B, Grudzien Meagan M, Zhang Qian, Hubbard Robert D, Wang Yi-Chun, Meulbroek Jonathan A, Jung Paul M, Pappano William N, Davidsen Steven K, Bell Randy L, Wang Jieyi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2009-09-01
|
Series: | BMC Cancer |
Online Access: | http://www.biomedcentral.com/1471-2407/9/314 |
Similar Items
-
The effects of IGF-I on the transcription of nuclear proto-oncogenes
by: QIU, XIAN-TAI, et al.
Published: (1992) -
IGF-binding protein 2 (IGFBP2) – oncogene or tumour suppressor?
by: Adam ePickard, et al.
Published: (2015-02-01) -
Overexpression of IGF2BP3 as a Potential Oncogene in Ovarian Clear Cell Carcinoma
by: Huidi Liu, et al.
Published: (2020-01-01) -
Autocrine IGF1 Signaling Mediates Pancreatic Tumor Cell Dormancy in the Absence of Oncogenic Drivers
by: Nirakar Rajbhandari, et al.
Published: (2017-02-01) -
Components of the Ret oncogene signalling pathway
by: Buchanan, V. S.
Published: (1999)